These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20104713)

  • 1. [The role of the family physician in the treatment concept of schizophrenic disorders].
    Jäger M; Riedel M; Möller HJ
    MMW Fortschr Med; 2006 May; Spec no. 2():39-41. PubMed ID: 20104713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenic patients in the family practice].
    Riedel M; Spellmann I; Müller N; Möller HJ
    MMW Fortschr Med; 2007 May; 149 Suppl 2():98-101. PubMed ID: 17724979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing schizophrenia in general practice.
    Blashki G; Keks N; Stocky A; Hocking B
    Aust Fam Physician; 2004 Apr; 33(4):221-7. PubMed ID: 15129465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch
    MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects].
    Bottlender R; Möller HJ
    MMW Fortschr Med; 2004 May; 146 Spec No 2():19-23. PubMed ID: 15376697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
    Burton S
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention for schizophrenic disorders. Implementing optimal treatment strategies in routine clinical services. OTP Collaborative Group.
    Falloon IR; Coverdale JH; Laidlaw TM; Merry S; Kydd RR; Morosini P
    Br J Psychiatry Suppl; 1998; 172(33):33-8. PubMed ID: 9764124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
    Kasper S
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems with the treatment of schizophrenics in the doctor's office].
    Sielk M
    MMW Fortschr Med; 2003 May; 145 Suppl 2():22-6. PubMed ID: 14579480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.